These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38059169)

  • 1.
    Wild C; Götz G; Wernly B
    Int J Cardiol Heart Vasc; 2023 Dec; 49():101299. PubMed ID: 38059169
    [No Abstract]   [Full Text] [Related]  

  • 2. Critical appraisal of "Goetz G, Wernly B, Wild C (2023) Wearable cardioverter defibrillator for preventing sudden cardiac death in patients at risk: An updated systematic review of comparative effectiveness and safety. IJC Heart & Vasculature 45 (2023) 101189". Comment to the authors reply.
    Semrau F; Nürnberg M
    Int J Cardiol Heart Vasc; 2024 Apr; 51():101390. PubMed ID: 38550274
    [No Abstract]   [Full Text] [Related]  

  • 3.
    Nürnberg M; Semrau F
    Int J Cardiol Heart Vasc; 2023 Oct; 48():101258. PubMed ID: 37680548
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
    Skowasch D; Ringquist S; Nickenig G; Andrié R
    PLoS One; 2018; 13(3):e0194496. PubMed ID: 29566033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wearable cardioverter defibrillator for preventing sudden cardiac death in patients at risk: An updated systematic review of comparative effectiveness and safety.
    Goetz G; Wernly B; Wild C
    Int J Cardiol Heart Vasc; 2023 Apr; 45():101189. PubMed ID: 37025482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wearable cardioverter-defibrillator in patients at risk of sudden cardiac death: consensus document from Kalarus et al. contradicts current guideline recommendations-Authors' reply.
    Tfelt-Hansen J; Svendsen JH; Kalarus Z; Capodanno D; Dan GA; De Maria E; Gorenek B; Jedrzejczyk-Patej E; Mazurek M; Podolecki T; Sticherling C; Traykov V; Lip GYH
    Europace; 2020 Sep; 22(9):1442-1443. PubMed ID: 32219381
    [No Abstract]   [Full Text] [Related]  

  • 7. Wearable cardioverter-defibrillator to reduce the transient risk of sudden cardiac death in coronary artery disease: Authors' reply.
    Tfelt-Hansen J; Svendsen JH; Kalarus Z; Capodanno D; Dan GA; De Maria E; Gorenek B; Jedrzejczyk-Patej E; Mazurek M; Podolecki T; Sticherling C; Traykov V; Lip GYH
    Europace; 2020 Oct; 22(10):1600-1601. PubMed ID: 32236547
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of the Wearable Cardioverter Defibrillator as a Bridge to Implantable Cardioverter Defibrillator.
    Weinstock J
    Card Electrophysiol Clin; 2018 Mar; 10(1):11-16. PubMed ID: 29428131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wearable cardioverter-defibrillator and ventricular arrhythmias: risk stratification in patients with shorter device use-Authors' reply.
    Kutyifa V
    Europace; 2019 Mar; 21(3):525-526. PubMed ID: 30561623
    [No Abstract]   [Full Text] [Related]  

  • 10. The wearable defibrillator: current technology, indications and future directions.
    Reek S
    Curr Opin Cardiol; 2017 Jan; 32(1):39-46. PubMed ID: 27755136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wearable cardioverter-defibrillators after myocardial infarction: a review of its clinical utility and unmet needs in current clinical practice.
    Hioki H; Kozuma K; Kobayashi Y; Ando K; Morino Y; Kishihara J; Ako J; Ikari Y
    Cardiovasc Interv Ther; 2022 Jan; 37(1):53-59. PubMed ID: 34195951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reply to: Comments on the authors' reply to the critical appraisal concerning "Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study".
    Ettinger S; Stanak M; Szymański P; Wild C; Tandara Haček R; Erčević D; Grenković R; Goetz G; Huić M
    Med Devices (Auckl); 2019; 12():129-131. PubMed ID: 30962728
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications for and outcome in patients with the wearable cardioverter-defibrillator in a nurse-based training programme: results of the Austrian WCD Registry.
    Odeneg T; Ebner C; Mörtl D; Keller H; Dirninger A; Stix G; Föger B; Grimm G; Steinwender C; Gebetsberger F; Stühlinger M; Mastnak B; Haider C; Manninger M; Scherr D
    Eur J Cardiovasc Nurs; 2019 Jan; 18(1):75-83. PubMed ID: 30064269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
    J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden cardiac death while waiting: do we need the wearable cardioverter-defibrillator?
    Israel C; Staudacher I; Leclercq C; Botto GL; Scherr D; Fach A; Duru F; Zylla MM; Katus HA; Thomas D
    Clin Res Cardiol; 2022 Nov; 111(11):1189-1197. PubMed ID: 35305126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wearable cardioverter defibrillator multicentre experience in a large cardiac surgery cohort at transient risk of sudden cardiac death.
    Kuehn C; Ruemke S; Rellecke P; Lichtenberg A; Joskowiak D; Hagl C; Hassan M; Leyh RG; Erler S; Garbade J; Eifert S; Grieshaber P; Boening A; Doenst T; Velichkov I; Madej T; Knaut M; Hain A; Burger H
    Eur J Cardiothorac Surg; 2022 May; 61(5):1031-1040. PubMed ID: 35174386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study.
    Garcia R; Combes N; Defaye P; Narayanan K; Guedon-Moreau L; Boveda S; Blangy H; Bouet J; Briand F; Chevalier P; Cottin Y; Da Costa A; Degand B; Deharo JC; Eschalier R; Extramiana F; Goralski M; Guy-Moyat B; Guyomar Y; Hermida JS; Jourda F; Lellouche N; Mahfoud M; Manenti V; Mansourati J; Martin A; Pasquié JL; Ritter P; Rollin A; Tibi T; Yalioua A; Gras D; Sadoul N; Piot O; Leclercq C; Marijon E
    Europace; 2021 Jan; 23(1):73-81. PubMed ID: 33257972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comments on the authors' reply to the critical appraisal concerning "Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study".
    Sperzel J; Staudacher I; Goeing O; Stockburger M; Meyer T; Gonçalves ASO; Sydow H; Schoenfelder T; Amelung V
    Med Devices (Auckl); 2018; 11():377-378. PubMed ID: 30425591
    [No Abstract]   [Full Text] [Related]  

  • 20. Real-world experience with the wearable cardioverter defibrillator: clinical effectiveness and wear-time adherence in patients at high risk for sudden cardiac death.
    Weth C; Abuazab H; Ewen S; Ukena C; Böhm M; Custodis F
    Herzschrittmacherther Elektrophysiol; 2022 Mar; 33(1):55-62. PubMed ID: 34694459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.